Description
Linaglip-M 5/1000 ER is an oral antidiabetic medication combining two agents:
-
Linagliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that increases incretin levels, enhancing insulin secretion and suppressing glucagon release, thereby lowering blood glucose levels.
-
Metformin Hydrochloride (Extended Release): A biguanide that decreases hepatic glucose production, reduces intestinal glucose absorption, and improves insulin sensitivity.
This combination provides a synergistic effect, offering improved glycemic control in adults with type 2 diabetes mellitus.
 1000 MG.jpg)
.webp)
.jpeg)
.webp)
.webp)
.jpeg)
 4ML.jpg)
Change Language